Mammogram vs. Ultrasound vs. Thermography: What to Know

Key Takeaways

• Mammography remains the primary screening tool. It's the most studied method for early breast cancer detection and the clinical starting point for most women.

• Breast density affects how imaging performs. Dense tissue can reduce mammography's sensitivity, leading providers to recommend additional imaging.

• Ultrasound is commonly used alongside mammography. Particularly in women with dense breasts, it can identify cancers that don't show up on X-ray.

• Thermography serves a different role than mammography or ultrasound. Current clinical guidelines don't support it as a standalone screening tool, though research into newer technologies continues.

• Imaging decisions are individualized. Your breast tissue type, risk factors, and clinical history all factor into which tools your provider may recommend.

  
  

If you've ever searched "breast imaging options" online, you've probably come across all three: mammography, ultrasound, and thermography. They're often discussed in the same breath, but they're not interchangeable, not in how they work, not in what they detect, and not in the role they play in your care.

Understanding the differences can help you have more informed conversations with your provider, make sense of your results, and know what questions to ask if follow-up imaging is recommended.

Mammography: The Gold Standard for Breast Cancer Screening

Mammography uses low-dose X-ray technology to capture detailed images of the breast's internal structures. It is the most extensively studied breast imaging tool available and remains the primary screening method recommended by major health organizations, including the American Cancer Society, the American College of Radiology, and the National Cancer Institute.

What it's looking for:

• Microcalcifications, the tiny calcium deposits that can be an early sign of cancer

• Masses or structural changes within breast tissue

• Early-stage cancers before any symptoms appear

  
  

What the data shows:

Mammography correctly identifies approximately 87% of women who have breast cancer, and consistent participation in screening has been shown to reduce breast cancer deaths by as much as 40% in regularly screened populations. That mortality reduction is significant, and it's why mammography is widely regarded as the only imaging modality to have demonstrated a measurable impact on survival rates at the population level.

Where it performs best, and where it has limits:

Mammography works best when breast tissue is primarily fatty, because fatty tissue appears dark on an X-ray while tumors appear white, a clear contrast that makes abnormalities easier to spot.

In women with dense breast tissue, that contrast disappears. Dense tissue also appears white on a mammogram, which can mask a tumor hiding beneath it. With increasing breast density, the sensitivity of mammography can drop from as high as 93% in fatty breasts to as low as 30% in extremely dense breasts, while false-positive rates also increase. This isn't a flaw in the technology. It's a physics reality, and it's exactly why breast density changes the conversation about what additional imaging might be needed.

One important note: mammography is the only imaging tool that reliably detects microcalcifications. Neither ultrasound nor thermography can visualize these tiny calcium deposits. This matters because microcalcifications are sometimes the earliest visible sign of breast cancer, long before a mass forms or symptoms appear. If microcalcifications are present, a mammogram is the tool most likely to find them.

Breast Density: Why It Changes Everything

Before diving into ultrasound, it's worth pausing to note that breast density is central to understanding why multiple imaging methods are sometimes used together.

Breasts are made up of fatty tissue, fibrous tissue, and glandular tissue. Women with a higher proportion of fibrous and glandular tissue are classified as having dense breasts. Approximately 40–50% of women fall into this category.

Dense breast tissue is not abnormal. But it does have two important implications:

1. It reduces mammography's ability to detect tumors clearly

2. It is itself an independent risk factor for developing breast cancer

This is why women with dense breasts are often advised to have supplemental imaging, not because the mammogram failed, but because an additional tool can provide information that an X-ray alone cannot. In fact, as of September 2024, the FDA now requires mammography facilities to notify patients in writing whether their breast tissue is dense and to inform them that other imaging tests may help find cancers in dense tissue.

Understanding your breast density category

When you receive a mammogram report, your breast density is classified using a four-category system called BI-RADS, developed by the American College of Radiology. According to the National Cancer Institute, the four categories break down as follows:

• Category A – Almost entirely fatty: Found in about 10% of women. Mammography performs at its highest sensitivity in this group.

• Category B – Scattered fibroglandular density: Found in about 40% of women. Mostly fatty tissue with some denser areas. Mammography generally performs well.

• Category C – Heterogeneously dense: Found in about 40% of women. Mostly dense tissue with some fatty areas. Mammography sensitivity begins to decrease, and supplemental imaging may be worth discussing with your provider.

• Category D – Extremely dense: Found in about 10% of women. Nearly all dense tissue. Mammography sensitivity is significantly reduced, and supplemental imaging is most strongly indicated.

Categories C and D are considered "dense breasts." If your report places you in either of these categories, it's a good reason to talk with your provider about whether additional imaging, such as ultrasound, makes sense for you.

Ultrasound: The Complementary Tool for Dense Tissue

Ultrasound uses sound waves, not radiation, to create real-time images of internal tissue. In breast imaging, it plays a different role than mammography: rather than serving as a primary screening tool, it's used to provide additional detail, clarify findings, and improve detection in tissue where mammography has limitations.

What it's designed to evaluate:

• Whether a finding is a solid mass or a fluid-filled cyst

• Specific areas of concern identified on a mammogram

• Breast tissue that is dense or difficult to assess on X-ray

  
  

Where ultrasound adds meaningful value:

In women with dense breast tissue, the addition of supplemental ultrasound to mammography has consistently shown the ability to find cancers that X-ray alone would miss. A large meta-analysis published in the British Journal of Cancer found that supplemental ultrasound detected an additional 3.8 cancers per 1,000 mammography-negative women with dense breasts — cancers that were invisible on mammography alone.

Multiple other studies, including the landmark ACRIN 6666 trial, have reported similar incremental detection rates of 3–4 additional cancers per 1,000 screens with physician-performed ultrasound.

For women with dense breasts, it can be the difference between early detection and a delayed diagnosis.

Ultrasound is also radiation-free, non-invasive, and can be performed in real time, which makes it well-suited for targeted evaluation of specific areas of concern.

What it doesn't replace:

Ultrasound is a complement to mammography, not a substitute for it. Mammography remains superior for detecting microcalcifications, the small calcium deposits that can signal very early cancer, which ultrasound typically cannot visualize. The two tools answer different questions, which is why they work best in combination when clinical circumstances call for it.

When is ultrasound used without mammography?

There are specific clinical situations where ultrasound may be used as the primary or sole imaging tool. According to the Society of Breast Imaging guidelines, these include:

• Women under 30, for whom ultrasound is typically the recommended first-line examination

• Pregnant or breastfeeding women, for whom radiation-based imaging is generally avoided unless medically necessary

• Evaluation of a specific palpable lump or area of focal concern in younger patients

Outside of these situations, ultrasound is not recommended as a standalone screening replacement for average-risk women. It is most valuable when used alongside mammography, particularly in women with BI-RADS Category C or D breast density.

How accurate is ultrasound on its own?

As a standalone tool, a large systematic review and meta-analysis published in JCO Global Oncology found that ultrasound has an overall pooled sensitivity of approximately 80% for detecting breast cancer. However, it has notable limitations: it cannot reliably characterize microcalcifications, it is highly operator-dependent, and it produces more false positives than mammography. These factors are why ultrasound is used to supplement mammography rather than replace it in most clinical settings.

Thermography: A Technology Worth Understanding With Important Caveats

Thermography uses infrared cameras to measure heat patterns on the surface of the skin. It doesn't use radiation, requires no compression, and is completely non-contact. These qualities have made it an appealing option for some women, particularly those who find mammograms uncomfortable or are wary of radiation exposure.

The idea behind it is biologically grounded: tumors require extra blood flow to grow, and that increased vascular activity can generate heat that shows up on an infrared image.

What current evidence and regulatory bodies say:

1. The FDA does not support thermography as a standalone breast cancer screening tool and has issued warning letters to providers who market it as a replacement for mammography. The American College of Radiology and the Society of Breast Imaging share this position, stating that no studies demonstrate a clear benefit of thermography alone or in combination with mammography in standard screening.

2. A major concern is the false positive rate. In at least one U.S. study, thermography incorrectly flagged breast cancer in 56% of women who did not actually have it, a rate that would result in far more unnecessary biopsies and follow-up procedures than current mammography already produces.

3. It's also important to understand what thermography cannot detect: because it only measures surface heat patterns, it has no ability to visualize internal breast structures. It cannot detect microcalcifications, masses, or structural changes within the breast tissue. If microcalcifications are present, thermography would not identify them.

Where the research is evolving:

That said, the thermography conversation isn't entirely closed. 

More recent research, particularly studies incorporating artificial intelligence and 3D infrared imaging, has shown more promising results in specific populations. One study found that AI-assisted thermography achieved a sensitivity of 87.5% in women with a genetic predisposition to breast cancer, outperforming mammography and ultrasound combined in that high-risk group. In a separate study of women with dense breasts, advanced thermography detected additional cancers beyond what mammography identified, increasing the detection rate meaningfully.

These findings are worth watching. But they represent emerging research, not established clinical practice. The current consensus among breast imaging specialists remains firm: thermography is not a validated standalone screening tool, and women should not forgo mammography in favor of it.

The most accurate way to describe thermography today is as a technology with biological logic and improving methodology that has not yet met the evidentiary bar for routine clinical use. That may look different in the future as AI-assisted imaging continues to advance.

How These Tools Fit Together

The question isn't really "which imaging is best." It's which combination of tools is right for a given patient's anatomy, risk profile, and clinical circumstances.

For most women, mammography is the starting point and remains the backbone of screening. For women with dense breast tissue, supplemental ultrasound can close a meaningful detection gap. Thermography, as it stands today, is best understood as a technology in development, not a clinical replacement for either.

What this means practically:

• Fatty breast tissue → Mammography performs at its highest sensitivity (up to 93%); supplemental imaging is often unnecessary

• Dense breast tissue → Mammography sensitivity can drop dramatically; supplemental ultrasound can detect several additional cancers per 1,000 screened that mammography alone would miss

• High-risk patients → Providers may recommend additional tools, including MRI, targeted ultrasound, or other imaging, alongside standard mammography

What to Ask Your Provider

If you've been told you have dense breast tissue, or if follow-up imaging has been recommended after a mammogram, these questions are worth asking:

• What type of breast tissue do I have, and how does that affect my screening results?

• Would supplemental ultrasound be appropriate for me?

• What is the goal of the additional imaging? Is it to clarify a specific finding, or to broaden the screening picture?

• How often should I be screened given my risk profile?

Understanding the tools your provider uses and why puts you in a much better position to be an active participant in your own care.

This post is intended for educational purposes and does not constitute medical advice. Please consult your healthcare provider to determine the screening approach that is right for you. Nola Diagnostic Ultrasound does not perform breast screenings or mammograms. All data and statistics referenced in this post are sourced from peer-reviewed research, clinical studies, and guidelines published by major medical organizations, including the American Cancer Society, the National Cancer Institute, the FDA, the Society of Breast Imaging, and the American College of Radiology.